ATTOVIA THERAPEUTICS, INC.

Consensus Attovia Therapeutics, Inc.

Stocks

ATTO

US04987L1026

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2026-10-07 pm EDT			5-day change	1st Jan Change
16.42 ^USD	-6.17%		-4.20%	-

Sep. 20	Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index	CI
Sep. 16	Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM

Evolution of the Average Target: Attovia Therapeutics, Inc.

Evolution of the Average Target - Attovia Therapeutics, Inc.

Evolution of the Target Price: Attovia Therapeutics, Inc.

Evolution of the Target Price - Attovia Therapeutics, Inc.

Changes in Analyst Recommendations: Attovia Therapeutics, Inc.

d3bed587fba1ed21d346ab5b.d0x2gfAr-z2g-Nb6X9YI0BCB3y5Qh9BoA07RtNCzzOs.DQY016dxrH_BupHOL7hZilnXsh4R9rUGSw2Ww6LVrd4DJwfCxn6dV9SIoQ~033db840e11a7f187328484d3c102f79

Analysts' recommendations: Attovia Therapeutics, Inc.

Aug. 31	Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC Says	MT
Aug. 31	Morgan Stanley Initiates Coverage on Attovia Therapeutics With Overweight Rating	MT
Aug. 31	Leerink Partners Initiates Attovia Therapeutics at Outperform With $52 Price Target	MT
Aug. 31	RBC Initiates Attovia Therapeutics at Outperform, Speculative Risk With $45 Price Target	MT
Aug. 31	Citigroup Initiates Attovia Therapeutics at Buy With $30 Price Target	MT

More recommendations

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ATTOVIA THERAPEUTICS, INC.	-	-			+141.14%
	WUXI APPTEC CO., LTD.					+13.99%
	ARGENX SE					+24.38%
	LONZA GROUP AG					+19.43%
	REVOLUTION MEDICINES, INC.					+29.48%
	IQVIA HOLDINGS INC.					+11.87%
	BEONE MEDICINES AG					+19.5%
	CELLTRION, INC.					+46.79%
	WUXI BIOLOGICS (CAYMAN) INC.					+0.6%
	BIONTECH SE					+21.55%
	Average					+32.87%
	Weighted average by Cap.					+20.51%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

5

Last Close Price

17.50USD

Average target price

42.20USD

Spread / Average Target

+141.14%

High Price Target

52.00USD

Spread / Highest target

+197.14%

Low Price Target

30.00USD

Spread / Lowest Target

+71.43%

Analyst Consensus Detail

Analyst consensus - Attovia Therapeutics, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Attovia Therapeutics, Inc.

Stock Market
Stocks
ATTO Stock
Consensus Attovia Therapeutics, Inc.

The best tools reserved for subscribers to boost the performance of your investments!

Maximize my profits

Maximize my profits